Insufficient Data
Stock has not been able to generate better return on equity than bank FD
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock in ASM list
—
—
—
Lasa Supergenerics Limited is engaged in the manufacturing of anthelmintics/veterinary active pharmaceutical ingredient (API). The Company also manufactures bulk drugs
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has decreased by 20.69%
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
3 weeks ago•Business Standard
3 weeks ago•The Hindu Businessline
1 month ago•Business Standard
Lasa Supergenerics Limited has informed the Exchange about press release dated 26-Apr-2022 titled ¬タワLASA SECURES BULK ORDER OF ¬ツᄍ 500 MILLION | Download
Lasa Supergenerics Limited has informed the Exchange about press release dated 26-Apr-2022 titled ¬タワLASA SECURES BULK ORDER OF ¬ツᄍ 500 MILLION | Download
Final • Div/Share: ₹ 0.25
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data